Document is current
Any future updates will be listed below
-
Authors
Idahl, Annika http://orcid.org/0000-0002-7865-4560
Liv, Per
Darelius, Anna
Collins, Elin
Sundfeldt, Karin
Pålsson, Mathias
Strandell, Annika
-
Funding
Funding for this research was provided by:
Cancerfonden (CAN 2017/464, CAN 21 1408 Pj)
Jane och Dan Olssons Stiftelse (2016-49)
Swedish governmental grants to researchers in the public health service (ALFGBG- 720291, ALFGBG-965130)
Swedish governmental grants to researchers in the public health service (ALFVLL-7000001, ALF VLL-7000003, ALFRV-7000003)
Governmental funding after regional HTA (HTA ALF 2016-86, 2017-01832)
Health and Medical Care Committee of the Regional Executive Board, Region Västra Götaland (VGFOUREG-650491, VGFOUREG-940745)
Cancer Research Foundation in Northern Sweden (AMP 17-859, LP 17-2169, LP 22-2314)
Regionala Forskningsrådet Uppsala/Örebro (RFR 652-621)
Umea University
- License Information
-
More Information
Article History
Received: 10 August 2022
Accepted: 13 March 2023
First Online: 24 March 2023
Declarations
:
: The HOPPSA study was approved by the Regional ethical review board in Gothenburg September 9, 2016 (Dnr 501–16). Amendments September 12, 2016 (Dnr 501–16); April 25, 2017 (Dnr T407-17); September 14, 2017 (Dnr T733-17). Each patient consents to participation in the GynOp registry and their inclusion in the trial.
: Not applicable.
: The authors declare no competing interests.
